Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer - Lu, Shun; Yu, Yongfeng; Zhou, Jianya; Li, Xingya; Goto, Koichi; Min, Xuhong; Nishino, Kazumi; Cui, Jiuwei; Wu, Ling; Sakakibara, Jun; Shu, Yongqian; Dong, Xiaorong; et al. (Translational Lung Cancer Research, 2025)